Spectra Medical Devices Acquires XL Precision Technologies 

Spectra Medical Devices Acquires XL Precision Technologies 

Spectra Medical Devices, a portfolio company of private equity firm QHP Capital, announced on September 30 that it entered into an agreement to acquire XL Precision Technologies.  XL Precision Technologies is a contract development and manufacturing organization (CDMO) specializing in the manufacture of precision micro-components, complex tubular components and sub-assemblies for the medical device industry. It is based in Stockton-on-Tees, England.  Spectra Medical Devices is one of the world’s leading manufacturers of made-to-spec procedural needles. Spectra is a CDMO to industry-leading, multi-national healthcare companies, global original equipment manufacturers and... Read More »
Winner Medical Acquires Global Resources International for $120 Million 

Winner Medical Acquires Global Resources International for $120 Million 

On September 26, Winner Medical announced that it acquired 75.2% equity of Global Resources International, Inc. (GRI) for $120 Million. According to data captured in the LevinPro HC database, this acquisition marks the 23rd contract development manufacturing organization transaction of the year.   Founded in 2000, GRI is a privately held corporation and a leading provider of comprehensive manufacturing and value-added services for medical devices, industrial products and protective solutions. Its products include surgical kits, drapes, sheets, containers, surgical gowns and industrial protective clothing.  Winner Medical is a manufacturer of disposable wound-care and surgical products... Read More »
Agilent to Acquire North American CDMO BIOVECTRA

Agilent to Acquire North American CDMO BIOVECTRA

Agilent Technologies Inc. announced that it has signed a definitive agreement to acquire BIOVECTRA, a specialized contract development and manufacturing organization (CDMO), for $925 million. BIOVECTRA produces biologics, highly potent active pharmaceutical ingredients and other molecules for targeted therapeutics. BIOVECTRA delivered $113 million in revenue during 2023 and expects double-digit revenue growth in 2024, according to a July 22 press release on BusinessWire. Agilent provides bio-analytical solutions and services to the life sciences, diagnostics and genomics, chemical analysis, communications and electronics industries worldwide. Its global headquarters is in Santa Clara,... Read More »
Winner Medical Acquires Global Resources International for $120 Million 

PE-Backed MedPharm Merges With CDMO Tergus Pharma

MedPharm, an Ampersand Capital Partners portfolio company, announced on July 8 a merger with Tergus Pharma, backed by Great Point Partners. The combined organization will operate under the MedPharm name, establishing a leading, end-to-end contract development and manufacturing organization (CDMO) with robust scientific, clinical trial manufacturing and commercial production capabilities. Tergus Pharma is a CDMO that provides formulation development, in vitro permeating testing, in vitro release testing, skin biology, analytical services and clinical manufacturing services for branded and generic dermatology products. MedPharm is an end-to-end contract service provider of topical and... Read More »
Agilent to Acquire North American CDMO BIOVECTRA

DuPont to Acquire Donatelle Plastics

DuPont announced it has signed an agreement to acquire New Brighton, Minnesota-based Donatelle Plastics. The transaction is expected to close in the third quarter 2024, subject to satisfaction of customary closing conditions and receipt of regulatory approvals. Donatelle Plastics is a medical device contract manufacturer specializing in the design, development and manufacture of medical components and devices. Founded in 1967, Donatelle Plastics has a workforce of more than 400 employees and operates a facility strategically located in a medical technologies hub near leading original equipment manufacturers. DuPont is an American multinational company that produces various products... Read More »
Agilent to Acquire North American CDMO BIOVECTRA

Siegfried Acquires Curia Global’s Early-Phase Manufacturing Site 

Siegfried announced on June 13 that it was expanding its global contract development management organization (CDMO) abilities with the acquisition of an early-phase manufacturing site in Grafton, Wisconsin from Curia Global.  The Wisconsin facility specializes in early-phase development and manufacturing services and employs more than 80 workers.  Siegfried develops and manufactures active pharmaceutical ingredients for pharmaceutical clients with R&D programs, related intermediates and controlled substances. Siegfried also offers the development and production of finished dosage forms, including sterile fillings. It is based in Zofingen, Switzerland.  Curia Global is a... Read More »